A. Meredith

发表

Mapping genetic markers on human chromosome 19 using subchromosomal fragments in somatic cell hybrids.

D. Shaw, P. Harper, J. Brook, 1986, Cytogenetics and cell genetics.

Specific molecular prenatal diagnosis for the CTG mutation in myotonic dystrophy.

D. Shaw, P. Harper, G. Norbury, 1992, Journal of medical genetics.

EXCLUSION TESTING FOR HUNTINGTON'S DISEASE IN PREGNANCY WITH A CLOSELY LINKED DNA MARKER

S. Youngman, P. Harper, M. Upadhyaya, 1987, The Lancet.

Mosaicism in Autosomal Dominant Polycystic Kidney Disease Revealed by Genetic Testing to Enable Living Related Renal Transplantation

A. Meredith, P. Lunt, A. Gardner, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Gene mapping and chromosome 19.

D. Shaw, P. Harper, M. Sarfarazi, 1986, Journal of medical genetics.

Bilateral split hand and split foot malformation in a boy with a de novo interstitial deletion of 7q21.3

S. Davies, A. Meredith, S. Roberts, 1991, Journal of medical genetics.

Linkage relationships of the insulin receptor gene with the complement component 3, LDL receptor, apolipoprotein C2 and myotonic dystrophy loci on chromosome 19

D. Shaw, P. Harper, G. Bell, 1986, Human Genetics.

Exclusion testing in pregnancy for Huntington's disease.

P. Harper, O. Quarrell, L. Lazarou, 1990, Journal of medical genetics.

Genetic analysis of treated and untreated phenylketonuria in one family.

P. Harper, M. Osborn, L. Tyfield, 1990, Journal of medical genetics.

Identification of the haplotype pattern associated with the mutant PKU allele in the Gypsy population of Wales.

P. Harper, M. Osborn, L. Tyfield, 1989, Journal of medical genetics.

one family . untreated phenylketonuria in Genetic analysis of treated and

P. Harper, M. Osborn, L. Tyfield, 2022 .

Genetic analysis oftreated anduntreated phenylketonuria inone family

A. Meredith, R. Primavesi, 1990 .

Direct sequencing of the complete CFTR gene: the molecular characterisation of 99.5% of CF chromosomes in Wales.

J. Cheadle, A. Meredith, M. Goodchild, 1993, Human molecular genetics.

Molecular genetics in clinical practice: evolution of a DNA diagnostic service.

P. Harper, M. Upadhyaya, A. Meredith, 1988, BMJ.

DNA markers . dystrophy by means of linked prenatal diagnosis for myotonic Presymptomatic detection and

P. Harper, A. Meredith, A. Norman, 2022 .

Determining sex in golden eagle (Aquila chrysaetos) nestlings

A. Meredith, N. Anderson, S. Ciavaglia, 2022, European Journal of Wildlife Research.

In vitro studies on calcium activated phosphatidylinositol phosphodiesterase of erythrocyte ghosts from normal individuals and those with myotonic muscular dystrophy.

P. Harper, A. Meredith, D. M. Bradley, 1982, Clinica chimica acta; international journal of clinical chemistry.

Myotonic dystrophy and gene mapping on human chromosome 19.

D. Shaw, J. Brook, A. Meredith, 1985, Biotechnology & genetic engineering reviews.

Application of a closely linked polymorphism of restriction fragment length to counselling and prenatal testing in families with myotonic dystrophy.

D. Shaw, P. Harper, M. Sarfarazi, 1986, British medical journal.

FIRST-TRIMESTER PREDICTION IN FETUS AT RISK FOR MYOTONIC DYSTROPHY

P. Harper, A. Meredith, P. Lunt, 1986, The Lancet.

Five years experience of predictive testing for myotonic dystrophy using linked DNA markers.

W. Reardon, P. Harper, L. Lazarou, 1992, American journal of medical genetics.

Huntington's disease: predictive testing and the molecular genetics laboratory

P. Harper, L. Lazarou, A. Meredith, 1993, Clinical genetics.

Two novel frame-shift mutations: 977 insA in exon 6B, and 4016 insT in exon 21, of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

J. Cheadle, A. Meredith, L. Al-Jader, 1993, Human molecular genetics.

Evidence against Linkage of von Recklinghausen Neurofibromatosis and Chromosome 19 Markers

D. Shaw, M. Sarfarazi, A. Meredith, 1986, Annals of the New York Academy of Sciences.

Linkage analysis of peripheral neurofibromatosis (Von Recklinghausen disease) and chromosome 19 markers linked to myotonic dystrophy.

D. Shaw, P. Harper, M. Sarfarazi, 1986, Journal of medical genetics.

Cystic fibrosis mutation analysis: Report from 22 U.K. regional genetics laboratories

M. Tassabehji, D. Barton, G. Taylor, 1995, Human mutation.

Sertoli cell tumour in an Amur tiger.

A. Meredith, C. Scudamore, 2001, Journal of comparative pathology.

Two CF patients, one homozygous for the 621 + 1G > T splice mutation, the other homozygous for the 1898 + 1G > A splice mutation.

J. Cheadle, A. Meredith, L. Millar-Jones, 1995, Journal of medical genetics.

Mild pulmonary disease in a cystic fibrosis child homozygous for R553X.

J. Cheadle, A. Meredith, M. Goodchild, 1992, Journal of Medical Genetics.

pound heterozygous for the 621 + 1 GGT and the 711 + 1 G. T mutations

A. Meredith, JP Cheadle, 2004 .

Severity of chest disease in cystic fibrosis patients in relation to their genotypes.

G. Owen, P. Harper, J. Cheadle, 1992, Journal of medical genetics.

Determining sex in golden eagle (Aquila chrysaetos) nestlings

A. Meredith, N. Anderson, S. Ciavaglia, 2022, European Journal of Wildlife Research.

Linkage analysis of peripheral neurofibromatosis (Von Recklinghausen disease) and chromosome 19 markers linked to myotonic dystrophy.

D. Shaw, P. Harper, M. Sarfarazi, 1986, Journal of medical genetics.

Presymptomatic detection and prenatal diagnosis for myotonic dystrophy by means of linked DNA markers.

A. Meredith, P. Harper, A. Norman, 1989, Journal of medical genetics.